BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10713045)

  • 1. Brain copper content and cuproenzyme activity do not vary with prion protein expression level.
    Waggoner DJ; Drisaldi B; Bartnikas TB; Casareno RL; Prohaska JR; Gitlin JD; Harris DA
    J Biol Chem; 2000 Mar; 275(11):7455-8. PubMed ID: 10713045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities.
    Wong BS; Brown DR; Pan T; Whiteman M; Liu T; Bu X; Li R; Gambetti P; Olesik J; Rubenstein R; Sy MS
    J Neurochem; 2001 Nov; 79(3):689-98. PubMed ID: 11701772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No superoxide dismutase activity of cellular prion protein in vivo.
    Hutter G; Heppner FL; Aguzzi A
    Biol Chem; 2003 Sep; 384(9):1279-85. PubMed ID: 14515989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant activity related to copper binding of native prion protein.
    Brown DR; Clive C; Haswell SJ
    J Neurochem; 2001 Jan; 76(1):69-76. PubMed ID: 11145979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein protects mice from lethal infection with influenza A viruses.
    Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
    PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein expression and superoxide dismutase activity.
    Brown DR; Besinger A
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):423-9. PubMed ID: 9716501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper binding to PrPC may inhibit prion disease propagation.
    Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
    Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.
    Perera WS; Hooper NM
    Curr Biol; 2001 Apr; 11(7):519-23. PubMed ID: 11413003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of superoxide dismutase activity by prion protein in vivo.
    Wong BS; Pan T; Liu T; Li R; Gambetti P; Sy MS
    Biochem Biophys Res Commun; 2000 Jun; 273(1):136-9. PubMed ID: 10873575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
    Rosenmann H; Talmor G; Halimi M; Yanai A; Gabizon R; Meiner Z
    J Neurochem; 2001 Mar; 76(6):1654-62. PubMed ID: 11259483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cellular prion protein in the neuron adaptation strategy to copper deficiency.
    Urso E; Manno D; Serra A; Buccolieri A; Rizzello A; Danieli A; Acierno R; Salvato B; Maffia M
    Cell Mol Neurobiol; 2012 Aug; 32(6):989-1001. PubMed ID: 22362149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
    Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
    Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant prion protein does not possess SOD-1 activity.
    Jones S; Batchelor M; Bhelt D; Clarke AR; Collinge J; Jackson GS
    Biochem J; 2005 Dec; 392(Pt 2):309-12. PubMed ID: 16156720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain.
    Pushie MJ; Pickering IJ; Martin GR; Tsutsui S; Jirik FR; George GN
    Metallomics; 2011 Feb; 3(2):206-14. PubMed ID: 21264406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.